DLN Drugs Private Limited - pharma in Puri, Odisha, India. FY 2026 financials & compliance.
CIN U51909OR2022PTC040047 Incorporated 21 June 2022 ROC Cuttack HQ Puri, Odisha, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹20.2 Cr
▲ 278% YoY
Net profit · FY 2024
₹22.38 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹77.1 Lakh
EBITDA margin 3.8%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹3.25 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About DLN Drugs Private Limited

Data last updated:

DLN Drugs Private Limited is a private limited company based in Puri, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 June 2022.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2022PTC040047. Its GSTIN is 21AAJCD3711B1ZG (Odisha).

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors Pradeep Kumar Pani and Kumudini Pani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No – 560/2637 1st Floor White Rose Pubasasan Kausalyaganga, Puri, Odisha, India – 751002.

As per the financials filed for FY 2024, the company reported a revenue of ₹20.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹22.38 Lakh (net margin 1.1%) and EBITDA of ₹77.1 Lakh (EBITDA margin 3.8%).

As per MCA filings, the company has open charges of ₹3.25 Cr on record.

DLN Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-26-0010340).

Company details

CIN U51909OR2022PTC040047
Registration Number 040047
Incorporation Date 21 June 2022
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-OD-26-0010340

Recognitions & Rankings of DLN Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-OD-26-0010340

Contact details

DLN Drugs Private Limited's registered office is in Puri, Odisha. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No – 560/2637 1st Floor White Rose Pubasasan Kausalyaganga, Puri, Odisha, India – 751002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of DLN Drugs Private Limited, buy the company report.

Comprehensive company report
DLN Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of DLN Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of DLN Drugs Private Limited, buy the company report.

Financials of DLN Drugs Private Limited

FY 2024 filings available

DLN Drugs Private Limited reported revenue of ₹20.2 Cr (up 278% YoY) for FY 2024.

Revenue · FY 2024
₹20.2 Cr ▲ 278%
Net profit · FY 2024
₹22.38 Lakh margin 1.1%
EBITDA · FY 2024
₹77.1 Lakh margin 3.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 278%
EBITDA CAGR growth
1 year
▲ 255%

Revenue rose 278% in the latest year. EBITDA rose 255% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹77.1 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22.38 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin3.8%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of DLN Drugs Private Limited, buy the company report.

Board of directors of DLN Drugs Private Limited

DLN Drugs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pradeep Kumar PaniDirector21 Jun 20224 Years 4 MonthsCurrent
Kumudini PaniDirector20 Feb 20251 Years 8 MonthsCurrent

Auditor

DLN Drugs Private Limited is audited by PBSD & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PBSD & ASSOCIATESFY 2023069913

Shareholding

The shareholding of DLN Drugs Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of DLN Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.25 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹3.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Nov 2022100653985State Bank of India₹3.25 CrOpen

To see the full charge records of DLN Drugs Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for DLN Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

DLN Drugs Private Limited has 1 active EPFO establishment as of Apr 07, 2024.

Active EPFO establishments
1

GST

DLN Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
21AAJCD3711B1ZGOdishaActive20 Oct 2022

To see the full GST registrations and return filing status of DLN Drugs Private Limited, buy the company report.

Recent activity

DLN Drugs Private Limited has 10 board changes on record since 2022: 6 appointments and 4 cessations. The latest: Prafulla Ch Khatua ceased to be Director on 18 Mar 2025.

AGM
Dln Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 3.25 Cr registered on 23 Nov 2022 with Charge ID 100653985 was modified on 19 Sep 2025.
Ceased
Prafulla Ch Khatua ceased to be Director.
Appointed
Kumudini Pani was appointed as Director.
Ceased
Sambit Karmakar ceased to be Director.
Appointed
Prafulla Ch Khatua was appointed as Director.
Filing
Dln Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Charges
A charge with State Bank Of India amounted to Rs. 3.25 Cr with Charge ID 100653985 was registered on 23 Nov 2022.
Ceased
Deepak Kumar Pani ceased to be Director.
Ceased
Jhuna Lata Pani ceased to be Director.
Appointed
Sambit Karmakar was appointed as Director.
Appointed
Deepak Kumar Pani was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

DLN Drugs is an active private limited company based in Puri, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 June 2022 (4+ years old) and is registered under CIN U51909OR2022PTC040047.

DLN Drugs has 2 current directors:

The latest financial statements of DLN Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of DLN Drugs is 21AAJCD3711B1ZG, registered in Odisha.

The CIN (Corporate Identification Number) of DLN Drugs is U51909OR2022PTC040047. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

DLN Drugs was incorporated on 21 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Cuttack.

Prafulla Ch Khatua ceased to be Director on 18 Mar 2025. Kumudini Pani was appointed as Director on 20 Feb 2025. Sambit Karmakar ceased to be Director on 02 Nov 2024. DLN Drugs has 10 board changes on record in total.

Yes, DLN Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-OD-26-0010340).

The registered office of DLN Drugs is at Plot No – 5602637 1st Floor White Rose Pubasasan Kausalyaganga, Puri, Odisha, India – 751002.

DLN Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.